51 – 60 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Prediction of bone loss using biochemical markers of bone turnover.
(
- Contribution to journal › Article
-
Mark
Latitude, socioeconomic prosperity, mobile phones and hip fracture risk.
(
- Contribution to journal › Article
-
Mark
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis
(
- Contribution to journal › Article
-
Mark
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial
(
- Contribution to journal › Article
- 2006
-
Mark
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective
(
- Contribution to journal › Article
-
Mark
Letter
(
- Contribution to journal › Letter
-
Mark
Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women.
(
- Contribution to journal › Article
-
Mark
Development of the Qualeffo-31, an osteoporosis-specific quality-of-life questionnaire
(
- Contribution to journal › Article
-
Mark
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men
(
- Contribution to journal › Debate/Note/Editorial